Outlook Therapeutics Inc ends fiscal 2Q with $58.4M in cash as it ramps up pre-commercial activities for wet AMD treatment ONS-5010 (Lytenava)
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Related Keywords